Viewing Study NCT06877533

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-02-06 @ 11:13 AM
Study NCT ID: NCT06877533
Status: TERMINATED
Last Update Posted: 2025-08-12
First Post: 2025-03-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors
Sponsor: iTeos Belgium SA
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Selected Advanced Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced solid tumors View
None Cancer View
None Phase I View
None Immunotherapy View
None Anticancer View
None Anti-PD1 View
None TREM2 View
None Pembrolizumab View
None EOS-215 View
None Metastatic View
None Antibodies View
None Monoclonal antibodies View
None Antineoplastic therapy View
None EOS006215 View